MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
31.85
+0.06 (0.19%)
At close: May 22, 2026, 4:00 PM EDT
32.03
+0.18 (0.57%)
After-hours: May 22, 2026, 6:45 PM EDT
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $1.52 billion as of May 22, 2026. Its market cap has increased by 287.32% in one year.
Market Cap
1.52B
Enterprise Value
1.08B
1-Year Change
287.32%
Ranking
Category
Stock Price
$31.85
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has increased from $509.66M to $1.52B, an increase of 197.45%. That is a compound annual growth rate of 90.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 1.52B | 7.04% |
| Dec 31, 2025 | 1.42B | 129.95% |
| Dec 31, 2024 | 615.88M | 20.84% |
| Sep 13, 2024 | 509.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Taysha Gene Therapies | 1.58B |
| Immatics | 1.56B |
| Damora Therapeutics | 1.56B |
| Vir Biotechnology | 1.55B |
| uniQure | 1.53B |
| GH Research | 1.52B |
| Novavax | 1.51B |
| Precigen | 1.51B |